Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder

Completed · Not applicable

Conditions studied: Obsessive-Compulsive Disorder

In brief

This study will evaluate the effectiveness of two cognitive behavioral therapies (CBTs) in treating obsessive compulsive disorder (OCD) in patients who are taking medication but still have residual symptoms.

Key facts

Study ID

NCT00045903

Run by

New York State Psychiatric Institute

People needed

136

Starts

2000-08-01

Expected to finish

2007-01-01

Last updated by the study team

2014-04-23

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Obsessive-Compulsive Disorder (OCD) diagnosis
• Currently taking a serotonin reuptake inhibitor (SRI, i.e. clomipramine, fluoxetine, fluvoxamine, paroxetine, sertraline, or citalopram) for OCD

You may not qualify if…

• Medical or psychiatric conditions that would make participation in the study hazardous
• Intensive cognitive-behavioral therapy while on an adequate dose and duration of an SRI for OCD

Where it is running

• New York State Psychiactic Institute, Anxiety Disorders Clinic — New York, New York, United States
• University of Pennsylvania Center for the Treatment and Study of Anxiety — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.